Markers of Iron Deficiency in Patients With Polycythemia Vera Receiving Ruxolitinib or Best Available Therapy

This exploratory analysis, the first to evaluate iron status in a prospective study of patients with polycythemia vera, investigated ruxolitinib effects on 7 serum iron markers and iron deficiency-related patient-reported outcomes.

 Leuk Res

click me